Upstream Bio, Inc.
UPB
$6.75
$0.396.13%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -97.98% | -128.39% | -128.90% | -157.91% | -176.57% |
| Total Depreciation and Amortization | 63.03% | 111.24% | 233.33% | 159.65% | 103.42% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 124.49% | 461.66% | 654.77% | 192.11% | 146.35% |
| Change in Net Operating Assets | 145.55% | -68.55% | -912.66% | -1,206.99% | -42.07% |
| Cash from Operations | -69.09% | -125.23% | -119.61% | -144.97% | -76.16% |
| Capital Expenditure | 67.71% | 67.71% | 9.20% | -- | -609.72% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 156.77% | -58.23% | -3.68% | -63.61% | -1,092.85% |
| Cash from Investing | 156.61% | -57.15% | -3.64% | -64.20% | -1,091.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.87% | -99.12% | 2,814.34% | 2,781.65% | 2,772.47% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -99.95% | -99.95% | 131.45% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 99.14% | -23.37% | -2,811.28% | -- |
| Cash from Financing | -99.25% | -99.42% | 83.61% | 79.94% | 452.46% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -36.46% | -174.71% | 376.64% | -122.46% | 1,204.71% |